Internal Medicine, Infectious Disease · Fort Pierce, FL
NPI
1457329450
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
356 E Midway Rd
Fort Pierce, FL, 34982
Phone (772) 464-9746
Groups this clinician bills Medicare through
Medicare paid, 2024
$243K
25,822 services
Medicare patients, 2024
818
Average age 73
Drug cost, 2024
$4.4M
2,391 prescriptions
Company payments, 2025
$148K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Moti N Ramgopal was code 99232 (hospital e&m - subsequent), 803 times for 394 patients. In total Moti N Ramgopal billed 25,822 services in 41 codes, and Medicare paid $243K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 803 | 394 | $65.03 | $52K |
| 99214 Office E&M - Established | Office | 460 | 244 | $94.98 | $44K |
| 99223 Hospital E&M - Initial | Facility | 302 | 282 | $142.61 | $43K |
| 36415 Venipuncture Blood Collection | Office | 287 | 138 | $8.65 | $2,483 |
| 99213 Office E&M - Established | Office | 195 | 136 | $66.75 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 115 | 95 | $97.72 | $11K |
| 96365 Intravenous Infusion, Hydration | Office | 112 | 15 | $50.85 | $5,695 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 110 | 14 | $0.53 | $57.83 |
| 96372 Injection Administration | Office | 99 | 26 | $8.94 | $886 |
| 99231 Hospital E&M - Subsequent | Facility | 85 | 63 | $41.05 | $3,489 |
| 99215 Office E&M - Established | Office | 75 | 47 | $122.51 | $9,188 |
| 99204 Office E&M - New | Office | 32 | 32 | $135.37 | $4,332 |
| 99222 Hospital E&M - Initial | Facility | 31 | 31 | $108.22 | $3,355 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 17 | 16 | $42.69 | $726 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 13 | 11 | $33.24 | $432 |
By year: 2022 $334K for 67,755 services; 2023 $181K for 16,907 services; 2024 $243K for 25,822 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 287 | 138 | $8.65 | $2,483 |
Medicare prescription drug claims, 2024
In 2024, the drug Moti N Ramgopal prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 405 prescriptions and refills. In total Moti N Ramgopal wrote 2,391 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 405 | 405 | 57 | $1.6M |
| Dovato Dolutegravir Sodium/Lamivudine | 185 | 185 | 25 | $542K |
| Cabenuva Cabotegravir/Rilpivirine | 134 | 249 | 31 | $864K |
| Atorvastatin Calcium Generic | 68 | 110 | 17 | $319 |
| Amlodipine Besylate Generic | 61 | 93 | 14 | $119 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 56 | 56 | Under 11 | $196K |
| Doxycycline Hyclate Generic | 49 | 71 | 22 | $621 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 63 | 16 | $389 |
| Juluca Dolutegravir/Rilpivirine | 46 | 46 | Under 11 | $154K |
| Tivicay Dolutegravir Sodium | 45 | 45 | Under 11 | $117K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 44 | 44 | Under 11 | $207K |
| Valacyclovir Valacyclovir Hcl | 40 | 60 | 12 | $1,906 |
| Azithromycin Generic | 39 | 77 | 17 | $690 |
| Megestrol Acetate Generic | 33 | 33 | Under 11 | $687 |
| Ceftriaxone Ceftriaxone Sodium | 32 | 32 | 11 | $2,090 |
Brand drugs: 1,189 claims; generic drugs: 1,202 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Moti N Ramgopal $148K ($148K in general payments such as food, travel and fees) from 10 companies. The largest payer was ViiV Healthcare Company with $76K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.